Long-Term Reoperation Rates After Open versus Minimally Invasive Spine Surgery for Degenerative Lumbar Disease: Five Year Follow-Up of 2130 Patients.
Document Type
Article
Publication Date
3-1-2023
Publication Title
World Neurosurgery
Abstract
BACKGROUND: Minimally Invasive Spine Surgery (MISS) is a growing alternative to Open Spine Surgery (OSS). The preservation of musculature and minimization of iatrogenic injury is hypothesized to decrease the need for reoperation by preserving normal anatomy. Our objective is to compare the relative long-term reoperation rates after MISS and OSS for the treatment of degenerative disease of the lumbar spine.
METHODS: This retrospective analysis compares the long-term reoperation rates after MISS and OSS. Eligible patients were adults with a primary lumbar intervention carried out between 5/1/2004 and 1/31/2014 to allow for at least 5 years of follow up. Patients without sufficient descriptive metrics or follow-up data were excluded. The primary outcome was the rate of lumbar spine reoperation.
RESULTS: A total of 2130 patients met the inclusion criteria-1895 underwent OSS and 235 underwent MISS. On average and across all surgery types (decompression and decompression with fusion), 28% of OSS patients required reoperation during the minimum 5-year follow up period while only 14% of MISS patients required reoperation (P = 0.001). The MISS group was statistically identical to the OSS group in all categories except that the MISS group was on average 1.8 years older (62.25 vs. 60.45, P = 0.039) and had a higher incidence of diabetes (26% vs. 17%, P = 0.000), but had a lower average body mass index than the OSS group (28.35 vs. 29.60, P = 0.002).
CONCLUSIONS: In the setting of degenerative lumbar spine disease, MISS has the potential to reduce the long-term need for reoperation when compared with OSS.
Volume
171
First Page
126
Last Page
136
Recommended Citation
Ramanathan S, Rapp A, Perez-Cruet M, Fahim DK. Long-term reoperation rates after open versus minimally invasive spine surgery for degenerative lumbar disease: five year follow-up of 2130 patients. World Neurosurg. 2023 Mar;171:e126-e136. doi: 10.1016/j.wneu.2022.11.100. PMID: 36442783.
DOI
10.1016/j.wneu.2022.11.100
ISSN
1878-8769
PubMed ID
36442783